Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever

Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever

Broad-spectrum antiviral drugs are preferred because they have the capacity to treat a range of viral illnesses rather than just one. Food and Drug Administration (FDA) approval of antiviral drugs to treat neglected tropical diseases is difficult to obtain due to ethical and logistical consideration...

Full description

Bibliographic Details
Main Authors:	Caroline, Amy L., Powell, Diana S., Bethel, Laura M., Oury, Tim D., Reed, Douglas S., Hartman, Amy L.
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983105/

Similar Items

Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus
by: Bales, Jacquelyn M., et al.
Published: (2012)

Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model
by: Caroline, Amy L., et al.
Published: (2016)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
by: Yamada, Kentaro, et al.
Published: (2016)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
by: Tani, Hideki, et al.
Published: (2016)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
by: Oestereich, Lisa, et al.
Published: (2014)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
by: Safronetz, David, et al.
Published: (2015)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
by: Gowen, Brian B., et al.
Published: (2013)

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
by: Mendenhall, Michelle, et al.
Published: (2011)

The Pathogenesis of Rift Valley Fever
by: Ikegami, Tetsuro, et al.
Published: (2011)

Rift Valley Fever Encephalitis
by: Alrajhi, Abdulrahman A., et al.
Published: (2004)

Rift Valley Fever in Chad
by: Ringot, David, et al.
Published: (2004)

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
by: de Ávila, Ana I., et al.
Published: (2016)

Rift Valley Fever in Goats, Cameroon
by: LeBreton, Matthew, et al.
Published: (2006)

RIFT VALLEY FEVER: LESSONS TO BE LEARNED
by: Alam, Awatif A., et al.
Published: (2000)

Rift Valley Fever in Namibia, 2010
by: Monaco, Federica, et al.
Published: (2013)

Potential Effects of Rift Valley Fever in the United States
by: Hartley, David M., et al.
Published: (2011)

The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
by: Jin, Zhinan, et al.
Published: (2013)

Rift Valley Fever Potential, Arabian Peninsula
by: Anyamba, Assaf, et al.
Published: (2006)

Rift Valley Fever, Sudan, 2007 and 2010
by: Aradaib, Imadeldin E., et al.
Published: (2013)

Unexpected Rift Valley Fever Outbreak, Northern Mauritania
by: El Mamy, Ahmed B. Ould, et al.
Published: (2011)

Observations on rift valley fever virus and vaccines in Egypt
by: Ahmed Kamal, Samia
Published: (2011)

Rift Valley Fever in Small Ruminants, Senegal, 2003
by: Chevalier, Véronique, et al.
Published: (2005)

Genome Analysis of Rift Valley Fever Virus, Mayotte
by: Cêtre-Sossah, Catherine, et al.
Published: (2012)

Prevalence of Rift Valley Fever among Ruminants, Mayotte
by: Cêtre-Sossah, Catherine, et al.
Published: (2012)

Rift Valley Fever in Ruminants, Republic of Comoros, 2009
by: Roger, Matthieu, et al.
Published: (2011)

The 2007 Rift Valley Fever Outbreak in Sudan
by: Hassan, Osama Ahmed, et al.
Published: (2011)

Rift Valley Fever Vaccine Development, Progress and Constraints
by: Kortekaas, Jeroen, et al.
Published: (2011)

Molecular Epidemiology of Rift Valley Fever Virus
by: Grobbelaar, Antoinette A., et al.
Published: (2011)

An Assembly Model of Rift Valley Fever Virus
by: Rusu, Mirabela, et al.
Published: (2012)

An Epidemiological Model of Rift Valley Fever with Spatial Dynamics
by: Niu, Tianchan, et al.
Published: (2012)

Novel approaches to develop Rift Valley fever vaccines
by: Indran, Sabarish V., et al.
Published: (2012)

Reemergence of Rift Valley Fever, Mauritania, 2010
by: Faye, Ousmane, et al.
Published: (2014)

Rift Valley Fever Outbreak, Southern Mauritania, 2012
by: Sow, Abdourahmane, et al.
Published: (2014)

Rift Valley Fever in Kedougou, Southeastern Senegal, 2012
by: Sow, Abdourahmane, et al.
Published: (2014)

Rift Valley Fever Outbreak in Livestock, Mozambique, 2014
by: Fafetine, José M., et al.
Published: (2016)

The Risk of Nosocomial Transmission of Rift Valley Fever
by: Al-Hamdan, Nasser A., et al.
Published: (2015)

Sociocultural and Economic Dimensions of Rift Valley Fever
by: Muga, Geoffrey Otieno, et al.
Published: (2015)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
by: Oestereich, Lisa, et al.
Published: (2016)

Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007
by: Ochieng, Caroline, et al.
Published: (2015)

Favipiravir elicits antiviral mutagenesis during virus replication in vivo
by: Arias, Armando, et al.
Published: (2014)